Little is known about how lactating women accommodate for their increased glucose demands during fasting to avoid maternal hypoglycemia. The objective of this study is to determine whether lactating women conserve plasma glucose by reducing maternal glucose utilization by increasing utilization of FFA and ketone bodies and/or increasing gluconeogenesis and mammary gland hexoneogenesis. Six healthy exclusively breastfeeding women and six non-lactating controls were studied during a 42h of fast and during 6h of re-feeding. Glucose and protein kinetic parameters were measured using stable isotopes and GCMS and energy expenditure and substrate oxidation using indirect calorimetry. After 42h of fasting, milk production decreased by 16% but remained within normal range. Glucose, insulin and C-peptide concentrations decreased with the duration of fasting in both groups but were lower (P<0.05) in lactating women. Glucagon, FFA and β-hydroxybutyrate concentrations increased with fasting time (P<0.001) and were higher (P<0.0001) in lactating women during both fasting and re-feeding. During 42h of fasting, gluconeogenesis was higher in lactating women when compared to non-lactating controls (7.7±0.4 vs. 6.5±0. 
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Introduction
Using new techniques to measure gluconeogenesis in vivo, we (4, 12, 18, 30) and others (13, 15) demonstrated that, gluconeogenesis accounts for approximately 50%
(ranging from 35 to 75%) of glucose production following an overnight fast. During carbohydrate absorption, plasma glucose and insulin concentrations increase simultaneously, but plasma glucose concentrations remain in a very narrow range in normal individuals. This fine control is mediated by glucose induced increase in plasma insulin, leading to increasing peripheral glucose utilization and glycogen synthesis, while hepatic glucose production is decreasing as a result of inhibited glycogenolysis (22) . In contrast, during fasting, plasma glucose and insulin concentrations decrease and plasma FFA, ketone bodies and glucagon concentrations increase (22) resulting in decreased glucose utilization and/or potentially increased glucose production to maintain euglycemia.
During a 24 h fast, glucose production in lactating women was ~35% higher than in non-lactating women presumably to meet the substrate needs for lactose synthesis (30) .
The increase in glucose production was the result of increased glycogenolysis since gluconeogenesis was essentially identical to that of the non-lactating controls. Over the course of the 24 h fast, rates of lipolysis and β-oxidation of fatty acids, as reflected by glycerol flux and ketonemia, were similar to those of non-lactating controls suggesting a lack of "mechanism(s)" to reduce glucose utilization in lactating women. However, the contribution of plasma glucose to lactose production decreased from 80% to 60% as a result of an increase in hexoneogenesis within the breast (28) .
Humans have limited hepatic glycogen storage capacity. After 40-42 h of fasting in men, the rate of glycogenolysis contributed only about 8% of total glucose production rate (13, 15) . In our previous study, we did not see a difference in glucose storage rate between lactating and non-lactating women in response to feeding (30) . By adding the extra demands imposed by lactation, we assume that beyond a 24 h fast, hepatic glycogen stores would be depleted more rapidly in the lactating than in the non-lactating women.
Despite these new insights, we still do not know if or how lactating women adapt to their increased glucose demands during extended fasting to avoid maternal hypoglycemia.
Therefore, we undertook the present studies to determine whether increasing the duration of fasting from 24 to 42 h in lactating women would result in: 1) increased glucose production via an increase in gluconeogenesis together with an increase in hexoneogenesis; 2) decreased glucose utilization by reducing milk production and/or maternal glucose utilization; and 3) increased utilization of FFA and ketone bodies. American-Hispanic and 1 Asian American] were recruited for the study. The infants of the lactating women weighed 5.69 ± 0.36 kg and were 11.0 ± 0.5 wk of age at the time of study.
Materials and Methods

Tracers
Study design.
Women were instructed to consume a diet providing approximately 50% carbohydrate, 15% protein and 35% fat for the week prior to admission. Lactating women were asked to bring 6 to 10 oz of breast milk to supplement their infants feeding should they have technical difficulty with breastfeeding and/or decreased milk production. Each woman and her infant were admitted to the GCRC before 4 PM on the afternoon prior to study (day 1). At 5 PM, one intravenous (IV) catheter was introduced in the woman's antecubital fossa or forearm vein under Emla® cream (Astra Pharmaceuticals, Wayne, PA) analgesia for blood sampling. Subjects were fed a supper meal of 10 kcal/kg at 6 PM and were subsequently fasted except for water ad libitum until the re-feeding portion of the protocol. Blood and milk samples were obtained at 6 PM and subsequently every 6 h until midnight on the last day of the study (day 3). Glucose concentrations were measured immediately at each blood draw. If the glucose decreased to < 60 mg/dL, an investigator was contacted and the frequency of glucose monitoring was increased. In addition, the mothers were carefully observed and at any signs and/or symptoms consistent with hypoglycemia, plasma glucose was immediately measured. If the glucose concentration decreased to < 40 mg/dL on a quantitative laboratory measure, the fast was terminated.
The mothers were requested to breast-feed their infants every 3 h. At each feeding, the infants were fed from both breasts. Infants were weighed before and after each breastfeeding to determine the volume of milk consumed (2, 19) . Following each feeding the mothers emptied their breasts completely using a standard electric breast pump (Playtex Embrace™, Dover, DE). The weight of the resulting milk was measured and an aliquot frozen for subsequent analysis. This volume of milk was added to that consumed by the infant at each breast-feeding to determine total milk production (2). h of fasting per day, thus, the adult 60 kg subject received ~1700 kcal/day). The purpose of this feeding strategy was to evaluate the subject's acute response to re-feeding not to
provide full caloric requirements. To avoid problems in data interpretation, both lactating and control subjects received the same caloric load of Boost HP®. CO 2 production and O 2 consumption were measured every 3 h from 6 AM through 6 PM using indirect calorimetry for calculation of substrate oxidations. 12 h urine collections were obtained during the first 36 h of the study followed by 6 h collections during the last 12 h. During collection, the urine was kept refrigerated and then frozen at -80 °C until nitrogen analyses and pH measurements were performed. Non-lactating women were studied using an identical protocol except no breast milk samples were obviously obtained.
Substrate and hormones determinations. Plasma glucose and lactate concentrations were determined using enzyme specific methods (YSI Glucose Analyzer, Yellow Springs, OH). Plasma insulin and C-peptide concentrations were measured using commercially available radioimmunoassay kits (Linco Research, Inc, St. Charles, MO). Plasma FFA and β-hydroxybutyrate concentrations were determined by microfluorometric enzyme analyses using Cobas Fara II Analyzer (Roche Diagnostic Systems, Inc., Montclair, NJ).
Blood urea nitrogen (BUN) concentration was measured calorimetrically using the Vitros analyzer (Ortho-Clinical Diagnostics, Rochester, NY). Plasma α-ketoisocaproate (α-KIC) concentrations were determined by GCMS and reverse isotope dilution using
KIC as an internal standard (27) . Lactose was hydrolyzed to glucose and galactose enzymatically and the resultant sugars analyzed individually as previously described (25, 28) . Milk lactose concentration was determined using an enzyme specific method (YSI Glucose Analyzer, Yellow Springs, OH). The concentration of protein was determined using Bicinchoninic Acid (BCA) protein assay kit (Novagen, Madison, USA) (14, 18) .
Urine pH was measured using a pH meter (Accumet Basic pH meter, Fisher Scientific, USA was determined using the 2-pyrimidinol-tert-butyldimethylsilyl derivative as previously described (11, 27) . Plasma α-[1-13 C]KIC enrichment was measured after derivatization to the oxime-tert-butyldimethylsilyl (TBDMS) derivative of α-KIC as previously described (27) . During the intravenous infusion of compounds labeled with stable isotopes (36-48 h), the fraction of glucose derived from gluconeogenesis was measured as previously described (4). Briefly, 2 H 2 O enrichment was measured using IRMS (4). The 2 H enrichment of glucose excluding C-2 was determined using the recently described method of Chacko, et al, (4) .
Indirect calorimetry. Indirect calorimetry was performed using a MedGraphic Model
Indirect Calorimeter (MedGraphics Inc., Minneapolis, Minnesota). Substrate oxidation rates for protein, glucose, lipid and resting energy expenditure were calculated using the gaseous exchange equations previously described (7) . The substrate oxidation rates were calculated as:
Lipid oxidation = 1.67 (VCO 2 -VO 2 ) -1.92N
Glucose oxidation = 4.55 VCO 2 -3.21 VO 2 -2.87N
Protein oxidation = N / 6.25
where VCO 2 and VO 2 are the L/min of gaseous exchange obtained from the calorimeter; N represents total nitrogen excretion (g/min) estimated from the urea Ra.
Calculations:
Total glucose entry and glucose production. The total rate of appearance (Ra) of glucose into the systemic circulation was calculated under near steady-state condition using the standard isotope dilution equation:
where E i and E p are the infusate and plasma enrichments, respectively, of the labeled glucose ([1-13 C] following 14 h fasting and [6, 6-2 H 2 ] following 42 h fasting and refeeding) and I is the rate of infusion of the labeled glucose.
In the fasting state, glucose production rate (GPR) was calculated by subtracting the amount of infused labeled glucose from the glucose R a :
GPR is the sum of the rates of gluconeogenesis (GNG) and glycogenolysis:
The fraction of glucose derived from gluconeogenesis (GNG) was determined using The rate of gluconeogenesis is:
The rate of glycogenolysis in the post absorptive state was calculated as the difference between glucose production and gluconeogenesis:
Glycogenolysis fasting = GPR -GNG.
During meal ingestion, the rate of appearance of dietary glucose into the plasma pool (R a-meal ) was estimated from the carbohydrate content in the Boost ® drink. We assumed that ~ 85% of orally ingested glucose entered the systemic circulation in the normal volunteer adults based on our previous studies (i.e. ~14g × 0.85/100 ml of drink consumed) (30) .
The rate of glycogenolysis during meal absorption was estimated as:
The fraction of glucose and galactose (product pool) in milk lactose that was derived from plasma glucose (precursor pool) and the fraction derived from de novo synthesis were calculated as previously described (25, 30) .
Urea production rate. The rate of appearance of urea into the systemic circulation was calculated under near steady-state condition using the standard isotope dilution equation:
where E i and E p are the infusate and plasma enrichments, respectively, of the labeled urea and I is the rate of infusion of the labeled urea (27) .
Rates of protein oxidation. Based on urea Ra, protein oxidation was calculated using the following equation:
Protein oxidation (g⋅kg
Where Urea Ra is expressed in g⋅kg -1 ⋅d -1 and 0.47 is the fraction of urea that is composed of nitrogen and 6.25 is the inverse of the fraction of nitrogen in protein.
Rate of proteolysis. Leucine appearance rate (R a-Leu ) was used as an indicator of proteolysis and was calculated using the reciprocal pool model using the [1-13 C]KIC enrichment according to the following equation.
where E i and E p are the enrichments of the leucine infusate and plasma KIC, respectively, and I is the rate of infusion of the labeled leucine. The rate of proteolysis (g⋅kg -1 ⋅d -1 ) was calculated using the following equation as previously described (27) :
where R a-Leu is leucine rate of appearance (µmol⋅kg
, 131 is its molecular weight, 1440 is to convert min to day, 10 -6 is to convert µg to g and 12.5 is the inverse of leucine content in body protein (~8%).
During fasting, proteolysis is derived solely from endogenous sources, while during feeding, it is the sum of the rate of entry of leucine from both endogenous and exogenous sources. Endogenous leucine entry can be calculated by subtracting exogenous leucine entry from total leucine Ra. The exogenous leucine entry was calculated based on the content of protein in the Sustacal drink as provided by manufacturer (27) .
The rate of protein synthesis was calculated using the following equation:
Proteolysis -Protein oxidation = Protein synthesis.
Insulin sensitivity. Insulin sensitivity in the fasting condition was calculated using the averaged baseline insulin and glucose values using the HOMA R and QUICKI methods analyses. Significance was defined as P < 0.05.
Results
Changes in substrate and hormone concentrations over time. Statistics were carried out using repeated measures ANOVA to demonstrate differences over time, differences between groups (non-lactating vs. lactating), and differences due to interaction of group and time (Figures 1-2) . Repeated measures ANOVA revealed a progressive decrease in the plasma glucose concentration in both groups (P < 0.001) with fasting time. The decrease was greater (P < 0.0001) in the lactating as compared to the non-lactating women ( Figure 1) . During re-feeding, plasma glucose rose in both groups (P < 0.001) but
was not different between the two groups (P = 0.09).
Insulin and C-peptide concentrations followed the same pattern as glucose i.e.
decreasing with the duration of the fasting and increasing (P < 0.0001) in the re-feeding period. However, only insulin was lower in the lactating (P < 0.01) compared to the nonlactating women during re-feeding (but not during fasting). In contrast, plasma glucagon concentrations increased with fasting (P < 0.0001) and were higher (P < 0.0001) in the lactating when compared to the non-lactating women. Re-feeding lowered glucagon concentration (P < 0.0001) but, the lactating women continued to have higher values (P < 0.001) than the non-lactating controls (Figure 1 ).
Lactate concentration fell with time (P < 0.0001) in both non-lactating controls and lactating women (Figure 2) . During re-feeding, the plasma lactate concentration increased (P < 0.01) in the non-lactating while it decreased (P < 0.01) in the lactating women. BUN concentrations were higher (P < 0.0001) in the lactating group during both fasting and re-feeding. FFA concentrations and β-hydroxybutyrate were higher (P < 0.0001) in the lactating group over the time course of fasting and re-feeding (P < 0.0001) (Figure 2 ).
Figure 1.
Mean ± SEM concentrations of plasma glucose, insulin, C-peptide and glucagon in the non-lactating ( ) (n = 6) and lactating (n = 6) ( ) women during the fasting (left panel) and re-feeding (right panel) states. Statistics were carried out using repeated measures ANOVA denoting differences overtime (A) and differences between groups (B) and difference due to interaction of group and time (AB). and lactating ( ) (n = 6) women during fasting and re-feeding. Statistics were carried out using repeated measures ANOVA denoting differences over time (A), differences between groups (B) and difference due to interaction of group and time (AB).
Plasma substrate and hormone concentrations at specific time points:
Plasma substrate concentrations. After 14 h of fasting, the plasma glucose concentrations were slightly lower in the lactating as compared to the non-lactating women (4.3 ± 0.1 vs. 4.6 ± 0.1, P = 0.04). Plasma lactate concentrations were also lower in the lactating group, whereas FFA, β-hydroxybutyrate, KIC and BUN were not different ( Table 1) . Lactate (mM) 30.7 ± 1.6 33.2 ± 3.1 50.9 ± 3.7 46.3 ± 7.3 47.9 ± 3.1 58.5 ± 7.9 n = 6 subjects in each group. Values are mean ± SEM. β-OH-BT = β-hydroxybutyrate; FFA = free fatty acids; BUN = blood urea nitrogen; KIC = ketoisocaproic acid. * P (nonpaired) < 0.05, ** P (non-paired) < 0.01, non-lactating (n = 6) vs. lactating (n = 6) women. Statistics related to the effect of fasting or feeding time on different parameters are presented in Figures 1-2 .
After 42 h of fasting, plasma glucose concentrations in lactating women remained lower than in non-lactating women (2.6 ± 0.1 vs. 3.6 ± 0.2 mM, P = 0.0002), respectively. No difference in plasma lactate or KIC concentrations was observed between the two groups, whereas both plasma β-hydroxybutyrate (4.3 ± 0.4 vs. 2.0 ± 0.4 mM, P = 0.007) and FFA (2.0 ± 0.2 vs. 1.5 ± 0.3, P = 0.04) were higher in lactating women. BUN concentrations were also higher in the lactating group (14.3 ± 1.1 vs. 10.4 ± 0.7 mg/dl, P < 0.05) ( Table 1) .
After 6 h of re-feeding, plasma concentration of glucose were not different between lactating and non-lactating women while plasma lactate concentrations were nearly twice as high (P < 0.01) in the non-lactating as compared to the lactating women.
Although plasma β-hydroxybutyrate and FFA concentrations decreased after re-feeding, FFA concentrations were three times higher in the lactating group (0.6 ± 0.1 vs. 0.2 ± 0.0 mM, P = 0.005) by the end of the study. Plasma KIC concentrations were not different, but BUN concentrations were higher in the lactating group (16.8 ± 0.6 vs. 13.2 ± 0.5 mg/dL, P < 0.01) ( Table 1) .
Hormone concentrations and insulin sensitivity. After the overnight fast, plasma insulin, C-peptide and glucagon were not different between the two groups ( Table 1) . After 42 h of fasting, insulin and C-peptide concentrations were not different between lactating and non-lactating groups. However, the plasma glucagon concentration was higher in the lactating women (119 ± 19 vs. 71 ± 3 pg/ml, P < 0.05). After 6 h of re-feeding, plasma concentration of insulin, C-peptide and glucagon concentrations were not different between the two groups.
After the overnight fast, insulin sensitivity as measured by HOMA (1.04 ± 0. First phase (ф1 × 10 -9 ) (335 ± 54 vs. 356 ± 74, P = 0.80) and second phase (ф2 × 10 -9 ) (13.9 ± 1.7 vs. 10.9 ± 1.8, P = 0.26) insulin secretory indices also were not different between the lactating and non-lactating groups.
Glucose kinetics. After the overnight fast, GPR was higher in the lactating as compared to the non-lactating women, respectively (13. Energy expenditure and substrate oxidations. After an overnight fast, there was no difference in energy expenditure between the non-lactating and the lactating women.
However, RQ and CHO oxidation were lower and fat oxidation was higher in the lactating group (Table 2) .
After 42 h of fast, energy expenditure was not different between the lactating and the non-lactating women. However, RQ was lower (0.73 ± 0.01 vs. 0.79 ± 0.02, P < 0.01) and fat oxidation was higher (1.8 ± 0.2 vs. 1.2 ± 0.2 g·kg -1 ·d -1 , P < 0.05) whereas that of CHO was lower (-0.2 ± 0.2 vs. 1.4 ± 0.5 g·kg -1 ·d -1 , P < 0.01) in the lactating as compared to the non-lactating group. During the re-feeding, energy expenditure was also not different between the two groups but fat oxidation remained higher (P < 0.05) and CHO oxidation remained lower (P < 0.05) in the lactating women. Urine pH. Repeated measures ANOVA revealed differences over time (P < 0.001), differences between groups (non-lactating vs. lactating) (P < 0.001), and differences due to interaction of group and time (P < 0.001) ( Table 3) . Using Post Hoc comparisons, the pH of the urine collected during the first 24 h of fasting was not different between nonlactating and lactating women. However, following 24 h of fasting, the pH was consistently lower in the lactating compared to the non-lactating (P < 0.01) women. From 24 h to 42 h of fasting, the pH decreased (6.5 ± 0.2 vs. 4.7 ± 0.1, P < 0.01) in lactating women; while, it remained unchanged in the non-lactating women (6.7 ± 0.2 vs. 6.1 ± 0.3, P > 0.05). After re-feeding, the pH did not increase in either the lactating or the nonlactating. However, it remained lower (P < 0.01) in lactating women. Table 3 . Urine pH in non-lactating and lactating women during fasting and re-feeding. Values are mean ± SEM. Repeated measures ANOVA revealed differences over time (P < 0.001), differences between groups (non-lactating (n = 4) vs. lactating (n = 5)) (P < 0.001), and differences due to interaction of group and time (P < 0.001). Different alphabets (based on Post Hoc comparisons) indicate significant difference (P < 0.05).
Milk production and composition. After an overnight fast, milk volume was 99 ± 7 ml/feeding (feeding represents 3h). The average milk productions reduced (P < 0.05) by 14% (86 ± 8 ml/feeding) following 42 h fasting and was not increased after 6 h of refeeding (88 ± 8 ml/feeding) ( Table 4) . Milk protein and lactose concentrations were not different between fasting and re-feeding. The percentage of lactose hexoses derived from mammary gland synthesis after 14 h and 42 h of fasting were not different (45 ± 3 and 46 ± 5%, P > 0.05). During re-feeding, hexoneogenesis of lactose moieties was entirely abolished. ## based on lactose derived from plasma glucose (%), milk volume and lactose concentration.
Discussion
In our previous studies of 14-24 h fasting lactating women, the plasma substrate and hormone concentrations were similar in lactating and non-lactating women despite a 30% increase in glucose demands in the lactating subjects. The increased glucose demands were met by increased rates of glycogenolysis (12, 30) . In the present study, we demonstrated that if the fast was merely extended by 18 h, the lactating women developed relative hypoglycemia, hyperketonemia and hyper free fatty acidemia when compared to the non-lactating controls.
Plasma insulin and C-peptide followed the same pattern as glucose (i.e. decreased with the duration of fasting) in both groups whereas plasma glucagon concentrations increased progressively with the time of fasting plateauing after 30 h at twice the basal concentrations in the lactating women. In the non-lactating women in the present study as well as in previously studied 3-day fasted women (9), plasma glucagon increased by only ~50% from 14 h to 42 h of the fast. It is interesting to speculate, as has been done previously (9, 16) , that the low plasma insulin and elevated glucagon may be the primary hormonal triggers to orchestrate the controlled mobilization of substrates, regulation of hepatic glucose production and substrate oxidation.
In the present study, glucose production rate was 30% higher in the lactating compared to the non-lactating women after 14 h of fasting, results similar to those obtained following an overnight fasting (12) and 24 h of fasting (30) . Extension of fasting to 42 h decreased glucose production rate by 30 and 40% in the non-lactating and lactating women, respectively, and was no longer different between the two groups. Rates of gluconeogenesis were, however, higher at 42 h of fasting in the lactating women contributing to 96 ± 1% of the glucose production as compared to 87 ± 3 % in the nonlactating women. Thus, glycogenolysis accounted for a very minor part of the glucose production rate after 42 h fasting with no difference between non-lactating and lactating women. Our findings agree with those reported by Katz and Tayek (13) , who reported that fractional gluconeogenesis increased from 41 to 92% between 12 and 40 h in fasting men. Similar results were reported by Landau et al (15) . These observations suggest that after 42 h of fasting, hepatic glycogen stores are essentially depleted. This also would suggest that the higher rates of glycogenolysis in the lactating women resulted in earlier depletion of hepatic glycogen stores than in the non-lactating women. Therefore, after 42 h of fasting, lactating women were relying nearly exclusively on gluconeogenesis for their glucose requirements.
One potential mechanism to conserve maternal glucose during fasting is to increase the production of lactose from other substrates within the mammary gland.
However, at 42 h of fasting, rates of mammary hexoneogenesis were not different from those observed following 14 h of fasting in the present study or 14-24 h of fasting in our previous studies (18, 28, 30) . Calculating the minimum amount of lactose derived directly from plasma glucose, i.e. the amount that could not be contributed from hexoneogenesis (1.6 µmol·kg -1 ·min -1 ) ( However, the lactating women were more acidotic as indicated by their higher plasma ketone body and FFA concentrations. This supposition is supported by the lower urine pH values in the lactating women. Metabolic acidosis increases renal ammoniagenesis as a mechanism to correct the metabolic acidosis (3, 6) . Glutamine is the primary substrate for renal ammonia production while the carbon skeleton is incorporated into renal glucose production (6, 8, 21, 23) . With extended fasting, the rate of proteolysis increased and, it is reasonable to speculate that the increased gluconeogenesis in the lactating compared to the non-lactating women may be attributed to the active contribution of renal gluconeogenesis. However, the increase in urea production in the lactating women might also indicate an increase in hepatic gluconeogenesis. Presumably both glycerol (24, 26 ) (a product of lipolysis) and amino acids (8, 17) provide the carbon needed for the hepatic gluconeogenesis. However, it is impossible to determine the veracity of this argument without considerably more invasive studies. Furthermore, indirect calorimetry data revealed that the lactating women had lower CHO and higher fat oxidation rates following both 42 h of fasting and re-feeding compared to the non-lactating women.
Thus, the increased rates of gluconeogenesis and decreased rates of glucose utilization and oxidation by maternal tissues, presumably by the higher availability of FFA and ketone bodies, conserved maternal glucose for milk lactose synthesis.
After re-feeding, glucose concentrations increased and glucose production rates decreased in both groups with no difference between lactating and non-lactating women.
Glucose production was almost entirely represented by gluconeogenesis, which was apparently decreased and corresponded to the 24 h fasting values previously reported in lactating and non-lactating women (30) . FFA and β-hydroxybutyrate decreased with refeeding, but their concentrations remained higher in the lactating group. Despite refeeding for 6 h (a total of 50% of daily requirement), sources of energy utilization did not return to normal (i.e. after 14 h fast). The non-lactating women recovered more rapidly and shifted to CHO oxidation, whereas, lactating women continued to rely on both fat and protein as energy sources. Thus, all dietary CHO was most likely delivered to the mammary gland for milk production.
With the ingestion of High Protein Boost® during the re-feeding period, the Ra of leucine (and thus the estimate of proteolysis) increased in both the lactating and nonlactating women. This most likely does not reflect an increased rate of endogenous proteolysis since in our previous studies endogenous proteolysis decreases with feeding (1, 10, 27) . The increase in urea production rate (and thus protein oxidation) could be the result of oxidation of the protein consumed since 25% of the calories are provided as protein and/or this could be due to the incomplete equilibration of the urea tracer over the associated with a further increase in protein oxidation suggesting that the dietary amino acids might be more readily utilized for protein synthesis, e.g. body tissue and/or milk proteins.
In summary, both the non-lactating and lactating women adapted to a 42 h fast by reducing endogenous glucose needs by similar mechanisms. However, due to the added demands imposed by lactation, the metabolic stress was greater in the lactating women as indicated by lowered glucose concentration, increased glucagon concentrations, decreased utilization of CHO, higher plasma concentrations of FFA and ketone bodies (presumed greater metabolic acidosis), and higher plasma concentrations and rates of urea production, which presumably reflect increased rates of amino acid deamination and availability of carbon to support the increased rate of gluconeogenesis.
The present study concluded that the lactating women as compared to the nonlactating women are at risk for fasting hypoglycemia if fasting is extended. Although milk production and composition were preserved, fasted lactating women were more acidotic and subjected to protein loss as reflected by increased proteolysis and protein oxidation and fat loss as indicated by increased fat mobilization and oxidation.
